Health Care
54 companies side by side, sorted by revenue, so you can see who is big in the sector and who turns it into profit.
| Company | Revenue | Year over year | Operating margin | Net profit | Net margin |
|---|---|---|---|---|---|
| UNH | $113.2B | +12% | 0% | $0B | 0% |
| MCK | $106.2B | +11% | 2% | $1.2B | 1% |
| CVS | $98.9B | +8% | 2% | $1B | 1% |
| COR | $83.7B | +6% | 0% | $-0.3B | 0% |
| CI | $68.5B | +5% | 4% | $1.7B | 2% |
| CAH | $65.6B | +19% | 1% | $0.5B | 1% |
| CNC | $53.6B | +10% | 2% | $1.1B | 2% |
| ELV | $50.7B | +12% | 3% | $1.2B | 2% |
| HUM | $39.6B | +23% | 5% | $1.2B | 3% |
| JNJ | $25.3B | +7% | 28% | $5.5B | 22% |
| LLY | $19.8B | +56% | 45% | $7.4B | 37% |
| MRK | $17.3B | +4% | 38% | $5.8B | 33% |
| ABBV | $15B | +12% | 27% | $0.7B | 5% |
| PFE | $14.5B | +5% | -22% | $2.7B | 19% |
| BMY | $13B | +6% | -6% | $3.3B | 26% |
| ABT | $11.2B | +8% | 12% | $1.1B | 10% |
| TMO | $11B | +6% | 17% | $1.7B | 15% |
| MDT | $9.8B | +10% | 19% | $1.2B | 13% |
| AMGN | $8.6B | +6% | 31% | $1.8B | 21% |
| GILD | $7B | +4% | 37% | $2B | 29% |
| DHR | $6.3B | +6% | 17% | $0.9B | 14% |
| SYK | $6B | +3% | 15% | $0.7B | 12% |
| BSX | $5.2B | +12% | 21% | $1.3B | 26% |
| GEHC | $5.1B | +7% | 10% | $0.4B | 8% |
| BDX | $4.7B | +5% | 2% | $-0.3B | -7% |
| UHS | $4.5B | +10% | 11% | $0.3B | 8% |
| IQV | $4.2B | +8% | 12% | $0.3B | 7% |
| REGN | $3.6B | +19% | 17% | $0.7B | 20% |
| LH | $3.5B | +6% | 11% | $0.3B | 8% |
| VTRS | $3.5B | +8% | -3% | $0B | 0% |
| DVA | $3.4B | +6% | 15% | $0.2B | 6% |
| HSIC | $3.4B | +6% | 6% | $0.1B | 3% |
| VRTX | $3B | +8% | 37% | $1B | 35% |
| ISRG | $2.9B | +19% | 34% | $0.8B | 28% |
| DGX | $2.8B | +7% | 14% | $0.2B | 9% |
| BAX | $2.7B | +3% | 4% | $0B | -1% |
| ZTS | $2.3B | +3% | 30% | $0.6B | 27% |
| ZBH | $2.1B | +9% | 19% | $0.2B | 11% |
| SOLV | $2B | −3% | 5% | $0B | 1% |
| A | $1.8B | +10% | 22% | $0.3B | 18% |
| EW | $1.6B | +17% | 31% | $0.4B | 23% |
| STE | $1.6B | +7% | 19% | $0.2B | 14% |
| RMD | $1.4B | +11% | 36% | $0.4B | 28% |
| INCY | $1.3B | +21% | 23% | $0.3B | 24% |
| WAT | $1.3B | +91% | 0% | $-0.1B | -6% |
| DXCM | $1.2B | +15% | 25% | $0.2B | 17% |
| COO | $1.1B | +8% | 0% | $-0.1B | -7% |
| IDXX | $1.1B | +14% | 36% | $0.3B | 24% |
| ALGN | $1B | +6% | 10% | $0.1B | 11% |
| MTD | $0.9B | +7% | 22% | $0.2B | 18% |
| VEEV | $0.9B | +16% | 33% | $0.3B | 30% |
| WST | $0.9B | +14% | 22% | $0.2B | 18% |
| PODD | $0.8B | +34% | 12% | $0.1B | 12% |
| RVTY | $0.7B | +7% | 14% | $0B | 6% |
Diagrams
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Bristol Myers SquibbApr–Jun 2026 · reported Jul 30, 2026Revenue $13B +6% Net margin 26 % -
Abbott LaboratoriesJan–Mar 2026 · reported Jul 28, 2026Revenue $11.2B +8% Net margin 10 % -
Thermo Fisher ScientificMar 2026 · reported May 1, 2026Revenue $11B +6% Net margin 15 % -
-
-
-
-
-
-
-
-
Universal Health ServicesMar 2026 · reported May 7, 2026Revenue $4.5B +10% Net margin 8 % -
-
Regeneron PharmaceuticalsMar 2026 · reported Apr 29, 2026Revenue $3.6B +19% Net margin 20 % -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
West Pharmaceutical ServicesJun 2026 · reported Jul 23, 2026Revenue $0.9B +14% Net margin 18 % -
-
New results in your inbox
When a big company reports, you get the diagram before anyone has time to comment on it. No spam, one-click unsubscribe.